GMAB: Bathi resik saben saham sajrone 12 wulan pungkasan genmab.com

Simbol lan logo merek Genmab (GMAB)

Genmab A/S monetizes exclusive patents through high royalties from blockbuster sales. The change in rolling net income per share clearly confirms this strategy, with the latest parameter standing at 1.17. Growth is driven by alliances with pharma behemoths to accelerate therapy, while indirect pricing power shifts primary financial risks onto partners utilizing the company's unique antibodies.

GMAB (Genmab A/S) riwayat Bathi resik saben saham (EPS TTM) saka 04.07.2022 nganti 10.11.2026

Rincian analitis perusahaan Genmab A/S

- rega saham lan prakiraan rega para ahli:
Kutipan saham Genmab A/S|GMAB - Konsensus nilai wajar
- informasi kapitalisasi pasar:
Biji pasar Genmab A/S|GMAB - Total Nilai Bisnis
- indikator nilai aset resik miturut neraca:
Nilai Buku saben Saham Genmab|GMAB - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku genmab.com|GMAB - Nilai Agregat Aset
- rincian struktur utang lan likuiditas bisnis:
Total Utang marang Modal Genmab A/S|GMAB - Tanggungan utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Genmab US|GMAB - Utang kumulatif perusahaan|Utang marang nilai buku Genmab A/S|GMAB - Gedhene kewajiban jangka dawa|Utang jangka cendhak perusahaan Genmab|Rasio cepet genmab.com
- indikator pendapatan resik lan kelipatan nilai:
GMAB - Bathi perusahaan|Bathi mangsa ngarep Genmab A/S|GMAB - Nilai perusahaan marang bathi resik|Prakiraan rega marang bathi Genmab|GMAB - Rasio nilai perusahaan marang wutah bathi|Pangali EV/EBITDA Genmab A/S|GMAB - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Genmab|GMAB - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan genmab.com|GMAB - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Genmab A/S
Analisis dhasar perusahaan:Genmab A/S - GMAB
Produk sing diprodhuksi Genmab AS

To objectively assess the operational efficiency of Genmab A/S, it is essential for investors to track the actual yield of each security. Fundamental net income per share TTM aggregates net income over the year and divides it by the number of shares, reflecting how successfully scientific freedom and oncological research are converted into financial results that determine the long-term value of the business.

Karo sapa Genmab A/S saingan

EXEL: Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi saben saham sajroning taun lumaku NUVL (nuvalent.com)|KYMR (Kymera) - Bathi resik saben saham sajrone 12 wulan pungkasan|IDYA: Bathi saben saham sajrone patang kuartal pungkasan|ELVN (Enliven Pharma) - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham (EPS TTM) ORIC Corp|Bathi saben saham sajrone rolas wulan pungkasan Relay Therapeutics (RLAY)|NRIX (nurixtx.com) - Bathi saben saham sajroning taun lumaku|Bathi resik saben saham (EPS TTM) TYRA (Tyra Biosciences)|Bathi resik saben saham sajroning taun lumaku Verastem Oncology|Monte Rosa Tx - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan Cullinan Corp|IMRX (Immuneering Corporation) - Bathi resik saben saham sajrone 12 wulan pungkasan|CCCC: Bathi saben saham sajrone patang kuartal pungkasan|BDTX (Black Diamond Therapeutics) - Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan Repare Therapeutics, Inc. RPTX|Bathi resik saben saham (EPS TTM) PMVP|karyopharm.com - Bathi saben saham sajrone 12 wulan pungkasan|Propanc Biopharma - Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi saben saham sajroning taun lumaku BGMS|AADI: Bathi resik saben saham sajrone 12 wulan pungkasan|Aileron Therapeutics - Bathi saben saham sajrone patang kuartal pungkasan|BPMC: Bathi resik saben saham (EPS TTM)|GlycoMimetics - Bathi saben saham sajroning taun lumaku|SWTX (SpringWorks Therapeutics) - Bathi resik saben saham (EPS TTM)